PET/CT in Diagnosing and Evaluating Therapy in Vasculitis

[1]  M. Alba,et al.  Advances in the diagnosis of large vessel vasculitis. , 2015, Rheumatic diseases clinics of North America.

[2]  F. Paparo,et al.  Giant Cell Arteritis: A Systematic Review of the Qualitative and Semiquantitative Methods to Assess Vasculitis with 18F-Fluorodeoxyglucose Positron Emission Tomography , 2014, BioMed research international.

[3]  H. Verberne,et al.  The Role of 18F-FDG PET/CT in Large-Vessel Vasculitis: Appropriateness of Current Classification Criteria? , 2014, BioMed research international.

[4]  M. Soussan,et al.  FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. , 2014, Autoimmunity reviews.

[5]  G. Hunder,et al.  Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. , 2013, Rheumatic diseases clinics of North America.

[6]  G. Kitas,et al.  The role of multimodality imaging in the evaluation of Takayasu arteritis. , 2013, Seminars in arthritis and rheumatism.

[7]  Q. Cao,et al.  FDG PET Imaging of Large-Vessel Vasculitis. , 2012, PET clinics.

[8]  M. Briel,et al.  The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  G. Treglia,et al.  Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review , 2011, Clinical Rheumatology.

[10]  John O. Prior,et al.  Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  Chang-Keun Lee,et al.  Evaluation of Disease Activity Using F-18 FDG PET-CT in Patients With Takayasu Arteritis , 2009, Clinical nuclear medicine.

[12]  P. Cluzel,et al.  Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? , 2009, Arthritis and rheumatism.

[13]  A. Heinzel,et al.  Assessment of Large-Vessel Involvement in Giant Cell Arteritis with 18F-FDG PET: Introducing an ROC-Analysis–Based Cutoff Ratio , 2008, Journal of Nuclear Medicine.

[14]  M. Heller,et al.  MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis , 2008, Annals of the rheumatic diseases.

[15]  L. Mortelmans,et al.  Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. , 2006, Arthritis and rheumatism.

[16]  E. Henze,et al.  Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study , 2004, Annals of the rheumatic diseases.

[17]  F. Strutz,et al.  Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  D. Agostini,et al.  Towards an optimal semiquantitative approach in giant cell arteritis: an 18F-FDG PET/CT case-control study , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  J. Marienhagen,et al.  18F-FDG PET as a diagnostic procedure in large vessel vasculitis—a controlled, blinded re-examination of routine PET scans , 2010, Clinical Rheumatology.